Biogennix’s flagship product brand, Morpheus, is an advanced bone graft product consisting of a moldable suspension of 1-2mm TrelCor granules in a rapidly absorbing, organic binder. Based on TrelCor technology, the granules provide enhanced bone formation due to the combination of a nanocrystalline surface with an HCA composition and interconnected pore structure that emulate human cancellous bone.
Morpheus bone graft product is a robust graft material that provides optimal handling characteristics during intraoperative placement. Morpheus is moldable, cohesive, mixable with autogenous bone, and leaves minimal residual material on surgical gloves following handling. The binder’s resistance to breakdown and irrigation facilitate secure placement and stabilization of the graft mass. It is then rapidly absorbed leaving behind the porous TrelCor granules, which are resorbed, remodeled, and replaced with bone over the next 6-12 months.
Unlike other porous ceramic materials, Morpheus provides the surgeon an advanced bone graft that is actively involved in the bone healing process